
Publications of Matteo Pecoraro
All genres
Journal Article (6)
1.
Journal Article
14 (1), 4632 (2023)
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification. Nature Communications 2.
Journal Article
117 (8), pp. 4099 - 4108 (2020)
Role for ribosome-associated quality control in sampling proteins for MHC class I-mediated antigen presentation. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 3.
Journal Article
16 (4), e9247 (2020)
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer. MOLECULAR SYSTEMS BIOLOGY 4.
Journal Article
10, 1485 (2019)
Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer. Frontiers in immunology 5.
Journal Article
215 (1), pp. 141 - 157 (2018)
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. Journal of Experimental Medicine 6.
Journal Article
36 (31), pp. 4381 - 4392 (2017)
Delta Np63 alpha promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82. Oncogene Meeting Abstract (1)
7.
Meeting Abstract
41 (Suppl. 4), pp. 85 - 86. Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Wien, September 28, 2018 - October 02, 2018. Karger, Basel (2018)
Spatial and temporal monitoring of neoantigen-specific T cells and T-cell receptors in a melanoma patient with secondary immune resistance to Ipilimumab. In Oncology Research and Treatment,